tradingkey.logo
搜尋

Zimmer Biomet Holdings Inc

ZBH
添加自選
93.930USD
-1.020-1.07%
收盤 07-31 16:00美東報價延遲15分鐘
18.17B總市值
24.29本益比TTM

關於 Zimmer Biomet Holdings Inc 公司

Zimmer Biomet Holdings, Inc. is a global medical technology company. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. It also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.

Zimmer Biomet Holdings Inc簡介

公司代碼ZBH
公司名稱Zimmer Biomet Holdings Inc
上市日期Jul 25, 2001
CEOTornos (Ivan)
員工數量17000
證券類型Ordinary Share
年結日Jul 25
公司地址345 E Main St
城市WARSAW
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編46580-2746
電話15742676131
網址https://www.zimmerbiomet.com/en
公司代碼ZBH
上市日期Jul 25, 2001
CEOTornos (Ivan)

Zimmer Biomet Holdings Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Ivan Tornos
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
83.19K
+18.64%
Mr. Suketu P. Upadhyay
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
69.48K
+11.80%
Mr. Chad F. Phipps
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
66.30K
+6.11%
Mr. Sang Yi
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
27.00K
-18.52%
Ms. Lori Winkler
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
10.19K
+7.91%
Ms. Betsy J. Bernard
Ms. Betsy J. Bernard
Independent Director
Independent Director
5.27K
--
Mr. Paul A. Stellato
Mr. Paul A. Stellato
Chief Accounting Officer, Vice President, Controller
Chief Accounting Officer, Vice President, Controller
5.23K
+20.18%
Mr. Jehanzeb Noor
Mr. Jehanzeb Noor
Senior Vice President, Chief Strategy, Innovation and Business Development Officer
Senior Vice President, Chief Strategy, Innovation and Business Development Officer
5.15K
+96.08%
Mr. Syed A. Jafry
Mr. Syed A. Jafry
Independent Director
Independent Director
4.06K
--
Mr. Robert A. Hagemann
Mr. Robert A. Hagemann
Independent Director
Independent Director
4.00K
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Ivan Tornos
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
83.19K
+18.64%
Mr. Suketu P. Upadhyay
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
69.48K
+11.80%
Mr. Chad F. Phipps
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
66.30K
+6.11%
Mr. Sang Yi
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
27.00K
-18.52%
Ms. Lori Winkler
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
10.19K
+7.91%
Ms. Betsy J. Bernard
Ms. Betsy J. Bernard
Independent Director
Independent Director
5.27K
--

常見問題

Zimmer Biomet Holdings Inc的前五大股東是誰?

Zimmer Biomet Holdings Inc的前五大股東如下:Mr. Ivan Tornos

哪個業務部門對Zimmer Biomet Holdings Inc的收入貢獻最大?

在2026Q4,Knees業務部門對Zimmer Biomet Holdings Inc的收入貢獻最大,創收3.32B,占總收入的40.36% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有